Pacira Pharmaceuticals Inc (PCRX) Insider Trading
- $1,702,348.30
- $212,284,233.46
- Sept. 13, 2024
- Andreas Wicki
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 5, 2017 | VP | 601 | $43.32 | Sell | $26,035.32 | |
| June 5, 2017 | President | 1,966 | $43.32 | Sell | $85,167.12 | |
| June 5, 2017 | CEO | 4,311 | $43.32 | Sell | $186,752.52 | |
| May 15, 2017 | CAO | 21,041 | $50.86 | Sell | $1,070,145.26 | |
| May 15, 2017 | President | 20,000 | $51.20 | Sell | $1,024,000.00 | |
| Jan. 17, 2017 | President | 20,000 | $38.53 | Sell | $770,600.00 | |
| Jan. 17, 2017 | CEO | 15,000 | $38.41 | Sell | $576,150.00 | |
| Aug. 15, 2016 | CEO | 15,000 | $45.32 | Sell | $679,800.00 | |
| Aug. 15, 2016 | President | 25,000 | $45.21 | Sell | $1,130,250.00 | |
| June 7, 2016 | VP | 938 | $47.66 | Sell | $44,705.08 | |
| June 6, 2016 | VP | 321 | $47.20 | Sell | $15,151.20 | |
| June 6, 2016 | CAO | 600 | $47.20 | Sell | $28,320.00 | |
| June 6, 2016 | Director | 900 | $46.95 | Sell | $42,255.00 | |
| April 15, 2016 | CEO | 25,000 | $64.14 | Sell | $1,603,500.00 | |
| Jan. 29, 2016 | SVP | 2,000 | $58.92 | Buy | $117,840.00 | |
| Jan. 27, 2016 | SVP | 500 | $62.50 | Buy | $31,250.00 | |
| Jan. 15, 2016 | CEO | 15,000 | $63.84 | Sell | $957,600.00 | |
| Jan. 12, 2016 | Director | 300 | $66.55 | Buy | $19,965.00 | |
| Jan. 12, 2016 | SVP | 1,000 | $66.00 | Buy | $66,000.00 | |
| Oct. 15, 2015 | CEO | 15,000 | $37.57 | Sell | $563,550.00 | |
| Sept. 11, 2015 | CFO | 5,000 | $61.37 | Buy | $306,850.00 | |
| Aug. 17, 2015 | Director | 3,000 | $60.02 | Sell | $180,060.00 | |
| July 15, 2015 | CEO | 15,000 | $67.78 | Sell | $1,016,700.00 | |
| April 15, 2015 | CEO | 25,000 | $90.50 | Sell | $2,262,500.00 | |
| April 10, 2015 | Director | 2,500 | $88.00 | Sell | $220,000.00 | |
| March 16, 2015 | Director | 5,000 | $95.34 | Sell | $476,700.00 | |
| March 13, 2015 | Director | 1,000 | $93.83 | Buy | $93,830.00 | |
| Feb. 6, 2015 | CFO | 15,000 | $111.22 | Sell | $1,668,300.00 | |
| Jan. 15, 2015 | CEO | 15,000 | $97.52 | Sell | $1,462,800.00 | |
| Jan. 12, 2015 | Director | 2,500 | $94.06 | Sell | $235,150.00 | |
| Dec. 29, 2014 | Director | 1,000 | $93.32 | Sell | $93,320.00 | |
| Dec. 5, 2014 | Director | 2,645 | $94.54 | Buy | $250,058.30 | |
| Nov. 7, 2014 | SVP | 230 | $86.62 | Buy | $19,922.60 | |
| Nov. 7, 2014 | CFO | 15,000 | $87.18 | Sell | $1,307,700.00 | |
| Oct. 10, 2014 | Director | 2,500 | $94.87 | Sell | $237,175.00 | |
| Sept. 29, 2014 | Director | 1,000 | $96.40 | Sell | $96,400.00 | |
| Aug. 29, 2014 | Director | 21,494 | $108.11 | Sell | $2,323,716.34 | |
| Aug. 27, 2014 | Director | 55,813 | $108.08 | Sell | $6,032,269.04 | |
| Aug. 26, 2014 | Director | 24,207 | $108.11 | Sell | $2,617,018.77 | |
| Aug. 25, 2014 | Director | 30,000 | $108.07 | Sell | $3,242,100.00 | |
| Aug. 11, 2014 | Director | 150,000 | $101.25 | Sell | $15,187,500.00 | |
| Aug. 8, 2014 | CFO | 15,000 | $99.63 | Sell | $1,494,450.00 | |
| Aug. 7, 2014 | Insider | 20,000 | $100.26 | Sell | $2,005,200.00 | |
| July 15, 2014 | CEO | 15,000 | $86.75 | Sell | $1,301,250.00 | |
| July 14, 2014 | Insider | 29,700 | $86.96 | Sell | $2,582,712.00 | |
| July 10, 2014 | Director | 2,500 | $84.41 | Sell | $211,025.00 | |
| June 6, 2014 | Director | 67,900 | $82.62 | Sell | $5,609,898.00 | |
| June 3, 2014 | Director | 68,000 | $80.69 | Sell | $5,486,920.00 | |
| May 27, 2014 | Director | 64,400 | $77.93 | Sell | $5,018,692.00 | |
| May 21, 2014 | Director | 3,600 | $77.80 | Sell | $280,080.00 |
Insiders are both buying and selling Pacira Pharmaceuticals Inc stock.
The insider traders at Pacira Pharmaceuticals Inc are: Andreas Wicki, Lauren Bullaro Riker, David M Stack, Kristen Marie Williams, David M. Stack, Paul J Hastings, James S Scibetta, Roy Winston, Max Reinhardt, Gary W Pace, Charles A Reinhart III, John P Phd Longenecker, Daryl Gaugler, Gary Patou, Mark A Kronenfeld, Charles Anthony Laranjeira, Jonathan Slonin, Taunia Markvicka, Luke Evnin, Mark Froimson, Richard Scranton, John Phd Longenecker, James B Jones, John Pratt, Fred A Middleton, Laura Brege, David Stack, Scott Braunstein, Anthony Molloy, James Scibetta, James B. Jones, Marcelo Bigal, Donald C Manning, James S. Scibetta, HASTINGS PAUL J, Dennis Mcloughlin, Kristen Williams, Dennis L Winger, Frank D Lee, and Lauren Riker
The most active insider trader at Pacira Pharmaceuticals Inc is Andreas Wicki with 38 trades.
Andreas Wicki has sold the most Pacira Pharmaceuticals Inc stock with a total value of $103,301,745.13.
Gary W Pace has bought the most Pacira Pharmaceuticals Inc stock with a total value of $714,610.00.
The most recent insider trade for Pacira Pharmaceuticals Inc was on Sept. 13, 2024.
The single biggest insider buy for Pacira Pharmaceuticals Inc was from James S Scibetta with a total value of $306,850.00 on Sept. 11, 2015.
The single biggest insider sell for Pacira Pharmaceuticals Inc was from Andreas Wicki with a total value of $15,187,500.00 on Aug. 11, 2014.